Hypercalcemia Unmasks Peripheral T-Cell Lymphoma, NOS: A Case Report

Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is an uncommon and aggressive subtype of mature T-cell lymphomas, representing a heterogeneous group of malignancies without specific defining immunophenotypic or genetic features. It often presents with systemic “B” symptoms, generalized lymphadenopathy, and extranodal involvement. Diagnosis requires the exclusion of other well-defined T-cell lymphoma subtypes through detailed histopathological and immunohistochemical evaluation. Hypercalcemia is a recognized paraneoplastic manifestation in various cancers, particularly in solid tumors and some hematological malignancies; however, it is rarely the initial presentation of PTCL-NOS. We report the case of a 53-year-old female who presented with persistent fatigue, and vague abdominal discomfort. Laboratory investigations revealed severe hypercalcemia with normal renal function and intact parathyroid hormone levels. Imaging demonstrated diffuse bone marrow infiltration without radiological evidence of lytic bone lesions. Bone marrow biopsy showed diffuse infiltration by atypical lymphoid cells, and immunohistochemistry confirmed the diagnosis of PTCL-NOS. Hypercalcemia was attributed to a paraneoplastic mechanism mediated by parathyroid hormone related protein by the lymphoma cells. Following initiation of combination chemotherapy all systemic symptoms improved. This case highlights an unusual presentation of PTCL-NOS, where severe hypercalcemia preceded other overt clinical signs. The absence of lytic lesions and the rapid correction of calcium levels with lymphoma-directed therapy further support a humoral paraneoplastic process rather than direct bone destruction. It also underscores the need for a thorough and systematic diagnostic workup in patients presenting with unexplained hypercalcemia, particularly when conventional etiologies have been excluded. It also highlights the importance of considering PTCL-NOS as part of the differential diagnosis in such atypical clinical scenarios, enabling timely diagnosis and appropriate management.

Publication Details

Journal
Journal of Carcinogenesis
Published
2025-08-31
DOI
https://doi.org/10.64149/j.carcinog.24.3s.264-268
Primary Topic
Bone health and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hypercalcemia Unmasks Peripheral T-Cell Lymphoma, NOS: A Case Report

Journal of Carcinogenesis
Bone health and treatments
article

Hypercalcemia Unmasks Peripheral T-Cell Lymphoma, NOS: A Case Report

article en

Abstract

Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is an uncommon and aggressive subtype of mature T-cell lymphomas, representing a heterogeneous group of malignancies without specific defining immunophenotypic or genetic features. It often presents with systemic “B” symptoms, generalized lymphadenopathy, and extranodal involvement. Diagnosis requires the exclusion of other well-defined T-cell lymphoma subtypes through detailed histopathological and immunohistochemical evaluation. Hypercalcemia is a recognized paraneoplastic manifestation in various cancers, particularly in solid tumors and some hematological malignancies; however, it is rarely the initial presentation of PTCL-NOS. We report the case of a 53-year-old female who presented with persistent fatigue, and vague abdominal discomfort. Laboratory investigations revealed severe hypercalcemia with normal renal function and intact parathyroid hormone levels. Imaging demonstrated diffuse bone marrow infiltration without radiological evidence of lytic bone lesions. Bone marrow biopsy showed diffuse infiltration by atypical lymphoid cells, and immunohistochemistry confirmed the diagnosis of PTCL-NOS. Hypercalcemia was attributed to a paraneoplastic mechanism mediated by parathyroid hormone related protein by the lymphoma cells. Following initiation of combination chemotherapy all systemic symptoms improved. This case highlights an unusual presentation of PTCL-NOS, where severe hypercalcemia preceded other overt clinical signs. The absence of lytic lesions and the rapid correction of calcium levels with lymphoma-directed therapy further support a humoral paraneoplastic process rather than direct bone destruction. It also underscores the need for a thorough and systematic diagnostic workup in patients presenting with unexplained hypercalcemia, particularly when conventional etiologies have been excluded. It also highlights the importance of considering PTCL-NOS as part of the differential diagnosis in such atypical clinical scenarios, enabling timely diagnosis and appropriate management.

Journal of CarcinogenesisVol. 24(3s)
Openalex Percentile: Top 66%
Bone health and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Hypercalcemia Unmasks Peripheral T-Cell Lymphoma, NOS: A Case Report · Journal of Carcinogenesis (2025) | TGRS Research Map | TGRS